These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34138573)

  • 1. Benzoheterocyclic Oxime Carbamates Active against
    van der Westhuyzen R; Mabhula A; Njaria PM; Müller R; Ngumbu Muhunga D; Taylor D; Lawrence N; Njoroge M; Brunschwig C; Moosa A; Singh V; Rao SPS; Manjunatha UH; Smith PW; Warner DF; Street LJ; Chibale K
    J Med Chem; 2021 Jul; 64(13):9444-9457. PubMed ID: 34138573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
    Fan YL; Wu JB; Ke X; Huang ZP
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
    Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
    Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy.
    Cheng YJ; Liu ZY; Liang HJ; Fang CT; Zhang NN; Zhang TY; Yan M
    Molecules; 2019 May; 24(10):. PubMed ID: 31137832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study.
    Reddy DS; Kongot M; Netalkar SP; Kurjogi MM; Kumar R; Avecilla F; Kumar A
    Eur J Med Chem; 2018 Apr; 150():864-875. PubMed ID: 29597169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.
    Wilson CR; Gessner RK; Moosa A; Seldon R; Warner DF; Mizrahi V; Soares de Melo C; Simelane SB; Nchinda A; Abay E; Taylor D; Njoroge M; Brunschwig C; Lawrence N; Boshoff HIM; Barry CE; Sirgel FA; van Helden P; Harris CJ; Gordon R; Ghidelli-Disse S; Pflaumer H; Boesche M; Drewes G; Sanz O; Santos G; Rebollo-Lopez MJ; Urones B; Selenski C; Lafuente-Monasterio MJ; Axtman M; Lelièvre J; Ballell L; Mueller R; Street LJ; Ghorpade SR; Chibale K
    J Med Chem; 2017 Dec; 60(24):10118-10134. PubMed ID: 29148755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in
    Khonde LP; Müller R; Boyle GA; Reddy V; Nchinda AT; Eyermann CJ; Fienberg S; Singh V; Myrick A; Abay E; Njoroge M; Lawrence N; Su Q; Myers TG; Boshoff HIM; Barry CE; Sirgel FA; van Helden PD; Massoudi LM; Robertson GT; Lenaerts AJ; Basarab GS; Ghorpade SR; Chibale K
    J Med Chem; 2021 Sep; 64(17):12790-12807. PubMed ID: 34414766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents.
    Lv K; Wang A; Tao Z; Fu L; Liu H; Wang B; Ma C; Wang H; Ma X; Han B; Wang A; Zhang K; Liu M; Lu Y
    Eur J Med Chem; 2019 Oct; 179():208-217. PubMed ID: 31254922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Pharmacological Evaluation of Some C
    Niveditha N; Begum M; Prathibha D; Sirisha K; Mahender P; Chitra C; Rao VR; Reddy VM; Achaiah G
    Chem Pharm Bull (Tokyo); 2020; 68(12):1170-1177. PubMed ID: 33268649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxime carbamate--discovery of a series of novel FAAH inhibitors.
    Sit SY; Conway CM; Xie K; Bertekap R; Bourin C; Burris KD
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1272-7. PubMed ID: 20036536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids.
    Arumugam N; Almansour AI; Suresh Kumar R; Ibrahim Alaqeel S; Siva Krishna V; Sriram D
    Bioorg Chem; 2020 Jun; 99():103799. PubMed ID: 32247109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of macrolides against Mycobacterium tuberculosis.
    Zhu ZJ; Krasnykh O; Pan D; Petukhova V; Yu G; Liu Y; Liu H; Hong S; Wang Y; Wan B; Liang W; Franzblau SG
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S49-63. PubMed ID: 18762153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
    Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K
    Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against
    Moure AL; Narula G; Sorrentino F; Bojang A; Tsui CKM; Sao Emani C; Porras-De Francisco E; Díaz B; Rebollo-López MJ; Torres-Gómez PA; López-Román EM; Camino I; Casado Castro P; Guijarro López L; Ortega F; Ballell L; Barros-Aguirre D; Remuiñán Blanco M; Av-Gay Y
    J Med Chem; 2020 May; 63(9):4732-4748. PubMed ID: 32275415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
    Rachakonda V; Alla M; Kotipalli SS; Ummani R
    Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds.
    Nefzi A; Appel J; Arutyunyan S; Houghten RA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5169-75. PubMed ID: 19632841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.
    Dos Santos Fernandes GF; de Souza PC; Moreno-Viguri E; Santivañez-Veliz M; Paucar R; Pérez-Silanes S; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Man Chin C; da Silva PB; Chorilli M; Solcia MC; Ribeiro CM; Silva CSP; Marino LB; Bosquesi PL; Hunt DM; de Carvalho LPS; de Souza Costa CA; Cho SH; Wang Y; Franzblau SG; Pavan FR; Dos Santos JL
    J Med Chem; 2017 Oct; 60(20):8647-8660. PubMed ID: 28968083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.